Soligenix
SNGX
#10882
Rank
C$7.76 M
Marketcap
C$0.52
Share price
-0.29%
Change (1 day)
-86.12%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2026 (TTM): -C$16.13 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$16.61 Million a decrease over its 2024 earnings that were of -C$13.11 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$16.13 Million-2.9%
2025 -C$16.61 Million26.72%
2024 -C$13.11 Million22.96%
2023 -C$10.66 Million-45.74%
2022 -C$19.64 Million11.88%
2021 -C$17.56 Million-32.37%
2020 -C$25.96 Million83.18%
2019 -C$14.17 Million11.57%
2018 -C$12.7 Million19.29%
2017 -C$10.65 Million33%
2016 -C$8.01 Million-19.7%
2015 -C$9.97 Million5.16%
2014 -C$9.48 Million
2010 -C$10.7 Million26.12%
2009 -C$8.49 Million75.1%
2008 -C$4.85 Million-45.38%
2007 -C$8.87 Million-22.84%
2006 -C$11.5 Million66.15%
2005 -C$6.92 Million-16.65%
2004 -C$8.3 Million13.28%
2003 -C$7.33 Million-11.88%
2002 -C$8.32 Million-59.44%
2001 -C$20.51 Million378.18%
2000 -C$4.29 Million-38.53%
1999 -C$6.98 Million-18.43%
1998 -C$8.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.41 B-222,070.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$14.84 B-90,591.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.73 B-65,535.84%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-C$25.45 Million 55.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-C$58.54 Million 256.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$3.18 B-19,503.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-C$3.86 Million-76.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$82.84 M-604.96%๐Ÿ‡บ๐Ÿ‡ธ USA